Abbott boosted by MitraClip approval
This article was originally published in Clinica
Executive Summary
Abbott will be breathing a sigh of relief after the US FDA approved its MitraClip transcatheter mitral valve repair device for the minimally-invasive treatment of mitral regurgitation (MR).